BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
May 18, 2010
View Archived Issues
Astellas Acquires OSI for $4B; Sweetened Bid Melts Hostility
After an unsuccessful $3.5 billion hostile takeover attempt, Astellas Pharma Inc. raised its acquisition offer for OSI Pharmaceuticals Inc. to $4 billion, and OSI agreed to a friendly buyout. (BioWorld Today)
Read More
ARCA Shares Get a Bounce on SPA OK for Beta-Blocker
Read More
Roxro Dodges Opioid, NSAID Traps; 'Smooth' Nod for Sprix
Read More
NewCo News: ElexoPharm's First License Deal Worth up to $41.6M from Merck
Read More
NuPathe Files for $86M IPO Ahead of Migraine Patch NDA
Read More
Clinic Roundup
Read More
Stock Movers
Read More
Other News To Note
Read More
ATS Roundup
Read More